WallStreetZenWallStreetZen

NASDAQ: NRC
National Research Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
National Research earnings were $24.8M for the trailing 12 months ending Dec 31, 2024, with -16.7% growth year over year. The latest NRC earnings report on Dec 31, 2024 announced Q4 2024 earnings of $6.6M, up 15.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRC reported annual earnings of $24.8M, with -20% growth. The next NRC earnings date is May 8, 2025.

NRC past earnings growth

How has NRC's earnings growth performed historically?

Company
-16.67%
Industry
20.18%
Market
63.03%
NRC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NRC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NRC's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NRC earnings history

Current Revenue
$143.1M
Current Earnings
$24.8M
Current Profit Margin
17.3%
NRC's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

NRC Return on Equity

Current Company
69.3%
Current Industry
9.6%
Current Market
34.1%
NRC's Return on Equity (69.3%)... subscribe to Premium to read more.
High Return on Equity Performance

NRC undefined

Current Company
19.7%
Current Industry
4.5%
NRC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRC announces earnings.

NRC undefined

Current Company
36.5%
Current Industry
7.9%
NRC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRC vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRC$41.31M$24.78M-4.18%$1.05
LFMD-$6.03M-$21.99MN/A-$0.53
HCAT-$25.69M-$69.50MN/A-$1.15
SOPH-$50.76M-$62.49MN/A-$0.95
SPOK$24.18M$14.97M-18.35%$0.74
View Top Health Information Service Stocks

NRC earnings dates

Next earnings date
May 8, 2025

National Research Earnings Reports & History FAQ

What were National Research's earnings last quarter?

On NRC's earnings call on Invalid Date, National Research (NASDAQ: NRC) reported Q4 2024 earnings per share (EPS) of $0.29, up 19.44% year over year. Total NRC earnings for the quarter were $6.56 million. In the same quarter last year, National Research's earnings per share (EPS) was $0.36.

If you're new to stock investing, here's how to buy National Research stock.

When does National Research report earnings?

The next NRC earnings date is Invalid Date. Add NRC to your watchlist to be reminded of National Research's next earnings date.

What was NRC's earnings growth in the past year?

As of National Research's earnings date in Invalid Date, National Research's earnings has grown -16.67% year over year. This is 36.84 percentage points lower than the US Health Information Services industry earnings growth rate of 20.18%. NRC earnings in the past year totalled $24.78 million.

Is National Research profitable or losing money?

As of the last National Research earnings report, National Research is currently profitable. National Research's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $24.78 million, a 19.98% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.